发明名称 ONCOLYTIC VACCINIA VIRUS CANCER THERAPY
摘要 Embodiments of the invention are directed methods that include a thymidine kinase deficient vaccinia virus. The methods include administering the vaccinia virus at increased viral concentrations. Further aspects of the invention include methods for inducing oncolysis or collapse of tumor vasculature in a subject having a tumor comprising administering to a subject administered at least 1×108 viral particles of a TK-deficient, GM-CSF-expressing, replication-competent vaccinia virus vector sufficient to induce oncolysis of cells in the tumor.
申请公布号 PT2136633(E) 申请公布日期 2016.02.22
申请号 PT20080732358T 申请日期 2008.03.17
申请人 SILLAJEN BIOTHERAPEUTICS, INC. 发明人 null, null
分类号 主分类号
代理机构 代理人
主权项
地址